Cargando…

Withaferin A: From Ancient Remedy to Potential Drug Candidate

Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultana, Tahira, Okla, Mohammad K., Ahmed, Madiha, Akhtar, Nosheen, Al-Hashimi, Abdulrahman, Abdelgawad, Hamada, Haq, Ihsan-ul-
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705790/
https://www.ncbi.nlm.nih.gov/pubmed/34946778
http://dx.doi.org/10.3390/molecules26247696
_version_ 1784622033834868736
author Sultana, Tahira
Okla, Mohammad K.
Ahmed, Madiha
Akhtar, Nosheen
Al-Hashimi, Abdulrahman
Abdelgawad, Hamada
Haq, Ihsan-ul-
author_facet Sultana, Tahira
Okla, Mohammad K.
Ahmed, Madiha
Akhtar, Nosheen
Al-Hashimi, Abdulrahman
Abdelgawad, Hamada
Haq, Ihsan-ul-
author_sort Sultana, Tahira
collection PubMed
description Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article reviews the literature about the pharmacological profile of WA with special emphasis on its anticancer aspect. We reviewed research publications concerning WA through four databases and provided a descriptive analysis of literature without statistical or qualitative analysis. WA has been found as an effective remedy with multifaceted mechanisms and a broad spectrum of pharmacological profiles. It has anticancer, anti-inflammatory, antiherpetic, antifibrotic, antiplatelet, profibrinolytic, immunosuppressive, antipigmentation, antileishmanial, and healing potentials. Evidence for wide pharmacological actions of WA has been established by both in vivo and in vitro studies. Further, the scientific literature accentuates the role of WA harboring a variable therapeutic spectrum for integrative cancer chemoprevention and cure. WA is a modern drug from traditional medicine that is necessary to be advanced to clinical trials for advocating its utility as a commercial drug.
format Online
Article
Text
id pubmed-8705790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87057902021-12-25 Withaferin A: From Ancient Remedy to Potential Drug Candidate Sultana, Tahira Okla, Mohammad K. Ahmed, Madiha Akhtar, Nosheen Al-Hashimi, Abdulrahman Abdelgawad, Hamada Haq, Ihsan-ul- Molecules Review Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article reviews the literature about the pharmacological profile of WA with special emphasis on its anticancer aspect. We reviewed research publications concerning WA through four databases and provided a descriptive analysis of literature without statistical or qualitative analysis. WA has been found as an effective remedy with multifaceted mechanisms and a broad spectrum of pharmacological profiles. It has anticancer, anti-inflammatory, antiherpetic, antifibrotic, antiplatelet, profibrinolytic, immunosuppressive, antipigmentation, antileishmanial, and healing potentials. Evidence for wide pharmacological actions of WA has been established by both in vivo and in vitro studies. Further, the scientific literature accentuates the role of WA harboring a variable therapeutic spectrum for integrative cancer chemoprevention and cure. WA is a modern drug from traditional medicine that is necessary to be advanced to clinical trials for advocating its utility as a commercial drug. MDPI 2021-12-20 /pmc/articles/PMC8705790/ /pubmed/34946778 http://dx.doi.org/10.3390/molecules26247696 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sultana, Tahira
Okla, Mohammad K.
Ahmed, Madiha
Akhtar, Nosheen
Al-Hashimi, Abdulrahman
Abdelgawad, Hamada
Haq, Ihsan-ul-
Withaferin A: From Ancient Remedy to Potential Drug Candidate
title Withaferin A: From Ancient Remedy to Potential Drug Candidate
title_full Withaferin A: From Ancient Remedy to Potential Drug Candidate
title_fullStr Withaferin A: From Ancient Remedy to Potential Drug Candidate
title_full_unstemmed Withaferin A: From Ancient Remedy to Potential Drug Candidate
title_short Withaferin A: From Ancient Remedy to Potential Drug Candidate
title_sort withaferin a: from ancient remedy to potential drug candidate
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705790/
https://www.ncbi.nlm.nih.gov/pubmed/34946778
http://dx.doi.org/10.3390/molecules26247696
work_keys_str_mv AT sultanatahira withaferinafromancientremedytopotentialdrugcandidate
AT oklamohammadk withaferinafromancientremedytopotentialdrugcandidate
AT ahmedmadiha withaferinafromancientremedytopotentialdrugcandidate
AT akhtarnosheen withaferinafromancientremedytopotentialdrugcandidate
AT alhashimiabdulrahman withaferinafromancientremedytopotentialdrugcandidate
AT abdelgawadhamada withaferinafromancientremedytopotentialdrugcandidate
AT haqihsanul withaferinafromancientremedytopotentialdrugcandidate